top of page
Summary of Cancer52 / PHE Event: Development in Data for Rare and Less Common Cancers
Cancer52 and PHE/NCRAS are delighted to be able to share a film and a report of the very successful Developments in Data for Rare and...
Summary of Cancer52 / PHE Event: Development in Data for Rare and Less Common Cancers
Cancer52 and PHE/NCRAS are delighted to be able to share a film and a report of the very successful Developments in Data for Rare and...
10th July 2019 All Members Meeting
The All Members meeting was a very informative and enjoyable session, which featured a mix of great speakers. Jennifer Mitchell and Laura...
‘Getting a better deal for people with rare and less common cancers: what we can learn from patients
On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...
‘Getting a better deal for people with rare and less common cancers: what we can learn from patients
On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...
4th April 2019 - Cancer52 Roundtable
Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less...
12 November 2019 Access To Data Working Group
This meeting is for members of Cancer52 only. For timings and further information please email info@cancer52.org.uk.
5 November 2019 PPASG Meeting
This meeting is for members of Cancer52 only. For timings and further information please email info@cancer52.org.uk.
16 October 2019 All Stakeholders Briefing
The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...
25 September 2019 Board Meeting
This meeting is for members of Cancer52 only. For timings and further information please email info@cancer52.org.uk.
bottom of page